NCT07149831View on ClinicalTrials.gov

A Clinical Trial Evaluating the Safety and Tolerability, Biodistribution and Radiation Dosimetry, and Pharmacokinetics of Flotufolastat F-18 Injection in Healthy Chinese Adults

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 7, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Prostate Cancer

Interventions

DRUG

Flotufolastat F-18 Injection

Single dose intravenous injection of Flotufolastat F-18 Injection . Serial whole-body PET scan will be obtain after injection, blood and urine collection after injection for the assessment of pharmacokinetics.

Trial Locations (1)

100089

RECRUITING

Chinese PLA General Hospital, Beijing

All Listed Sponsors

lead

Sinotau Pharmaceutical Group

INDUSTRY